US · USD
ARWR
Arrowhead Pharmaceuticals Inc
- Day's range
- $60.56 – $63.19
- Day's volume
- $103M
- 52-week range
- $35.41 – $89.59
Follow ARWR in the Fuolio
See how ARWR weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountARWR in numbers
- Market cap
- $8.7B
- P/E
- -27.17
- P/B
- 18.67
- Dividend yield (12m)
- 0.00%
ARWR price history
ARWR risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +16.77% | +190.28% | -12.15% |
| Volatility (annualized) | 41.26% | 68.24% | 63.78% |
| Largest drawdown | -27.30% | -60.31% | -81.81% |
| Positive months | 6/12 | 19/36 | 26/60 |
How much did investing in ARWR return?
$1,000.00 invested on 11/01/2021 would be worth $878.52 today.
- Value today in ARWR
- $878.52
- Return over the period
- -12.15%
- Return per year
- -2.59%
- In the S&P 500
- $1,712.05
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
ARWR fundamentals
Valuation
- P/E-27.17
- P/B18.67
- EV/EBITDA-42.96
- EV/EBIT-38.39
- EV/Revenue12.98
- P/EBIT-38.39
- P/S12.98
- P/OCF-147.20
- P/FCF-115.73
- Earnings yield-2.60%
- PEG ratio—
- Earnings per share-$2.27
- Book value per share$3.30
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio5.90
- Quick ratio—
- Cash ratio—
Efficiency
- Gross margin—
- EBITDA margin-30.22%
- Operating margin-33.82%
- Net margin-47.79%
- Asset turnover0.32
Profitability
- ROE-68.73%
- ROA-15.15%
- ROIC-48.64%
- Payout—
Growth
- Revenue CAGR (5 years)44.13%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
ARWR's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | -5,528.14 | -3.90 | -16.01 | -24.42 | -49.20 | -93.25 | 89.31 | -21.04 |
| P/B | 19.35 | 12.61 | 12.12 | 10.79 | 16.95 | 17.07 | 24.82 | 11.96 |
| EV/EBITDA | 74.80 | — | — | — | — | — | 95.02 | — |
| Earnings per share | -$0.01 | -$4.82 | -$1.91 | -$1.66 | -$1.35 | -$0.82 | $0.71 | -$0.59 |
| Book value per share | $3.43 | $1.49 | $2.53 | $3.76 | $3.91 | $4.49 | $2.56 | $1.04 |
| ROE | -0.35% | -323.27% | -75.65% | -44.18% | -34.45% | -18.31% | 27.79% | -56.84% |
| ROIC | 12.33% | -322.67% | -75.55% | -44.79% | -36.45% | -20.17% | 24.95% | -58.39% |
| EBITDA margin | 14.53% | -16,451.14% | -80.71% | -69.81% | -103.00% | -101.10% | 37.85% | -327.94% |
| Net margin | -0.20% | -16,882.37% | -85.27% | -72.39% | -101.85% | -96.09% | 40.27% | -337.32% |
ARWR's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $829.4M | $3.6M | $240.7M | $243.2M | $138.3M | $88M |
| Cost of revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| EBITDA | $120.5M | -$584.2M | -$194.3M | -$169.8M | -$142.4M | -$89M |
| EBIT | $98.3M | -$601.1M | -$205M | -$178.5M | -$149M | -$93.2M |
| Financial result | -$46.8M | -$11.4M | -$1.5M | $5.8M | $8.2M | $8.6M |
| Income before tax | $51.5M | -$612.5M | -$206.5M | -$172.7M | -$140.8M | -$84.6M |
| Income tax | -$21.4M | $2.8M | -$2.8M | -$3.8M | -$2K | -$2K |
| Net income | -$1.6M | -$599.5M | -$205.3M | -$176.1M | -$140.8M | -$84.6M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does ARWR pay dividends?
ARWR has no distributions on record.
About Arrowhead Pharmaceuticals
- Sector
- Manufacturing
Questions about ARWR
How much is ARWR today?
ARWR is at $61.54 (-1.30% on the day), last traded on 10/06/2026.
What are the P/E and P/B of ARWR?
ARWR trades at a P/E of -27.17 and a P/B of 18.67.
How much did ARWR return in 12 months?
ARWR returned 16.77% in 12 months, with annualized volatility of 41.26% and a largest drawdown of -27.30%.